The market for Seasonal Affective Disorder is expected to grow at a CAGR of around 3.5% from 2020 to 2027 and expected to reach the market value of around US$ 667.5 Mn by 2027.
Seasonal Affective Disorder (SAD) refers to a type of depression associated with the changes in seasons. It begins and ends at about the same time every year. The treatment of SAD may include light therapy, medications, and psychotherapy. The most likely signs and symptoms of SAD may include feeling depressed most of the day, having low energy, losing interest in activities once enjoyed, feeling sluggish or agitated, having problems with sleeping, experiencing changes in appetite or weight, having difficulty concentrating, feeling hopeless, worthless or guilty, and having frequent thoughts of death or suicide. The disorder is commonly found in women and between 15 to 55 years of age.
Market Dynamics
The growing awareness regarding mental health, especially depression across the globe is supporting the regional market growth. The changing lifestyle along with rapid urbanization and hectic work-life schedules are bolstering the market growth. The increasing number of physician visits related to seasonal affective disorder in developed and developing economies is further bolstering market growth. The availability and adoption of new treatments for this disorder owing to the ongoing research and development efforts made by the major players are supporting the market growth. Additionally, rapid technological advancement and ongoing R&D activities in emerging economies are projected to create potential opportunities over the forecast period from 2020 to 2027.
On the other hand, low prevalence rate, less awareness of this disorder, and limited access to the healthcare facilities in some untapped economies are projected to limit the growth to an extent over the forecast period.
Segment Instance
North America accounted for the maximum share in the Seasonal Affective Disorder market
In 2019, North America is leading the market with maximum revenue share (%) in the seasonal affective disorder market. The well-established healthcare infrastructure of the developed economies including the US and Canada is supporting the regional market value. The ongoing efforts made by the major authorities to spread awareness and appropriate ways to deal with the early symptoms are boosting the regional market growth. Moreover, SAD is estimated to affect 10 million Americans and another 10% to 20% may have the mild seasonal affective disorder (SAD). Additionally, according to some estimates in Washington, seasonal affective disorder (SAD) has begun to collide with Covid-19 pandemic fatigue and other mental health issues exacerbated by the social isolation of lockdown, which has been exacerbated by the failed political response to the coronavirus pandemic. The increasing number is the result of mounting psychological distress due to rising unemployment and direct or indirect loss of belongings.
Moreover, Asia Pacific is likely to experience the fastest growth throughout the forecast timeframe from 2020 to 2027. The developing healthcare sector and rapid urbanization are supporting regional market growth. The increasing hectic and busy work-life culture in the fast pace market condition, rising competition among people in terms of money, and positions are other factors supporting the market growth. The rapidly developing economies including China and India are the major contributors to the regional market growth.
Key Market Players
The players profiled in the report include AbbVie Inc. (US), Allergan (Republic of Ireland), Bayer AG (Germany), Bristol-Myers Squibb Company (US), F. Hoffmann-La Roche Ltd. (Switzerland), Henry Schein Inc. (US), Pfizer Inc. (US), and others. The major market players were involved in mergers and acquisitions, partnerships & collaborations, and new source development for the expansion of market share (%).
Market Segmentation
Market By Type
Fall and winter SAD
Spring and summer SAD
Others
Market By Treatment
Light Therapy (Phototherapy)
Medications
Others
Market By End User
Hospital
Clinic
Household
Other
Market By Geography
North America
Europe
- UK
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
CHAPTER 1. Industry Overview of Seasonal Affective Disorder
1.1. Definition and Scope
1.1.1. Definition of Seasonal Affective Disorder
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Seasonal Affective Disorder Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Seasonal Affective Disorder Market By Type
1.2.3. Seasonal Affective Disorder Market By Treatment
1.2.4. Seasonal Affective Disorder Market By End User
1.2.5. Seasonal Affective Disorder Market by Regions
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restrain 1
3.2.2. Restrain 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Seasonal Affective Disorder Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Seasonal Affective Disorder Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2019
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Seasonal Affective Disorder Market By Type
4.1. Introduction
4.2. Seasonal Affective Disorder Revenue By Type
4.2.1. Seasonal Affective Disorder Revenue (US$ Mn) and Forecast, By Type, 2016-2027
4.2.2. Fall and winter SAD
4.2.2.1. Fall and winter SAD Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.3. Spring and summer SAD
4.2.3.1. Spring and summer SAD Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
4.2.4. Others
4.2.4.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 5. Seasonal Affective Disorder Market Revenue By Treatment
5.1. Introduction
5.2. Seasonal Affective Disorder Revenue (US$ Mn) By Treatment
5.2.1. Seasonal Affective Disorder Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027
5.2.2. Light Therapy (Phototherapy)
5.2.2.1. Light Therapy (Phototherapy) Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.3. Medications
5.2.3.1. Medications Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
5.2.4. Others
5.2.4.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 6. Seasonal Affective Disorder Market By End User
6.1. Introduction
6.2. Seasonal Affective Disorder Revenue (US$ Mn) By End User
6.2.1. Seasonal Affective Disorder Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
6.2.2. Hospital
6.2.2.1. Hospital Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.3. Clinic
6.2.3.1. Clinic Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.4. Household
6.2.4.1. Ultraviolet-visible spectroscopy Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
6.2.5. Others
6.2.5.1. Others Market Revenue (US$ Mn) and Growth Rate (%), 2016-2027
CHAPTER 7. North America Seasonal Affective Disorder Market By Country
7.1. North America Seasonal Affective Disorder Overview
7.2. U.S.
7.2.1. U.S. Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
7.2.2. U.S. Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016-2027
7.2.3. U.S. Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
7.3. Canada
7.3.1. Canada Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
7.3.2. Canada Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016-2027
7.3.3. Canada Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
7.4. North America PEST Analysis
CHAPTER 8. Europe Seasonal Affective Disorder Market By Country
8.1. Europe Bioanalytical Testing Services Market Overview
8.2. U.K.
8.2.1. U.K. Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.2.2. U.K. Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016-2027
8.2.3. U.K. Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.3. Germany
8.3.1. Germany Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.3.2. Germany Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016-2027
8.3.3. Germany Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.4. France
8.4.1. France Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.4.2. France Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016-2027
8.4.3. France Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.5. Spain
8.5.1. Spain Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.5.2. Spain Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016-2027
8.5.3. Spain Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.6. Rest of Europe
8.6.1. Rest of Europe Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016-2027
8.6.2. Rest of Europe Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016-2027
8.6.3. Rest of Europe Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By End User, 2016-2027
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Seasonal Affective Disorder Market By Country
9.1. Asia Pacific Seasonal Affective Disorder Market Overview
9.2. China
9.2.1. China Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.2.2. China Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027
9.2.3. China Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.3. Japan
9.3.1. Japan Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.3.2. Japan Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027
9.3.3. Japan Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.4. India
9.4.1. India Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.4.2. India Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027
9.4.3. India Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.5. Australia
9.5.1. Australia Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.5.2. Australia Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027
9.5.3. Australia Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.6. South Korea
9.6.1. South Korea Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.6.2. South Korea Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027
9.6.3. South Korea Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
9.7.2. Rest of Asia-Pacific Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027
9.7.3. Rest of Asia-Pacific Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Seasonal Affective Disorder Market By Country
10.1. Latin America Seasonal Affective Disorder Market Overview
10.2. Brazil
10.2.1. Brazil Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.2.2. Brazil Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027
10.2.3. Brazil Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.3. Mexico
10.3.1. Mexico Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.3.2. Mexico Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027
10.3.3. Mexico Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
10.4. Rest of Latin America
10.4.1. Rest of Latin America Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
10.4.2. Rest of Latin America Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027
CHAPTER 11. Middle East & Africa Seasonal Affective Disorder Market By Country
11.1. Middle East & Africa Seasonal Affective Disorder Market Overview
11.2. Saudi Arabia
11.2.1. Saudi Arabia Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.2.2. Saudi Arabia Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027
11.2.3. Saudi Arabia Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.3. UAE
11.3.1. UAE Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.3.2. UAE Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027
11.3.3. UAE Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Type, 2016 - 2027
11.4.2. Rest of Middle East & Africa Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By Treatment, 2016 - 2027
11.4.3. Rest of Middle East & Africa Seasonal Affective Disorder Market Revenue (US$ Mn) and Forecast By End User, 2016 - 2027
CHAPTER 12. PLAYER ANALYSIS OF STROKE MANAGEMENT
12.1. Seasonal Affective Disorder Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Seasonal Affective Disorder Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. COMPANY PROFILE
13.1. AbbVie Inc. (US)
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (US$ Mn), 2019
13.1.3.2. AbbVie Inc. (US) 2019 Seasonal Affective Disorder Business Regional Distribution
13.1.4. Product/ Service and Specification
13.1.5. Recent Developments & Business Strategy
13.1.6. Manufacturing Plant Footprint Analysis
13.2. Allergan (Republic of Ireland)
13.3. Bayer AG (Germany)
13.4. Bristol-Myers Squibb Company (US)
13.5. F. Hoffmann-La Roche Ltd. (Switzerland)
13.6. Henry Schein Inc. (US)
13.7. Pfizer Inc. (US)
13.8. Others
